Retinal dystrophy

Clinical trials for Retinal dystrophy

2 trials across Europe

See all trials →

Quick filters

2 Clinical trials

Retinal dystrophy

Not yet recruiting

A Study of ATSN-201 Gene Therapy for Patients with X-linked Retinoschisis (RS1-associated) to Assess Safety and Visual Function

InvestigationalNo placebo

A Study of ATSN-201 Gene Therapy for Patients with X-linked Retinoschisis (RS1-associated) to Assess Safety and Visual Function

InvestigationalNo placebo

France

Participants:0–17 years · 18–64 years · 65+ years
Substances:Ziloretgene parvec
Sponsor:Atsena Therapeutics Inc.

Contact Research Centre

Retinal dystrophy

Not yet recruiting

Safety and early effectiveness study of VG801 subretinal injection in patients with ABCA4 mutation-associated retinal dystrophy

InvestigationalNo placebo

Safety and early effectiveness study of VG801 subretinal injection in patients with ABCA4 mutation-associated retinal dystrophy

InvestigationalNo placebo

Germany

Participants:0–17 years · 18–64 years
Substances:VG801-1
Sponsor:VeonGen Therapeutics GmbH